menu
    • menu

    Company profile for BlueRock Therapeutics

    NEW Drugs in Dev: 5
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BlueRock is using its unique cell+gene platform to direct cellular differentiation and genetically engineer cells to create an entirely new generation of cellular medicines in the areas of neurology, cardiology, and immunology. The convergence of cell biology and genetic engineering is creating fundamental new ways to impact disease. Founded in 2016 to capitalize on these technological breakthroughs, we are advancing our novel...
    BlueRock is using its unique cell+gene platform to direct cellular differentiation and genetically engineer cells to create an entirely new generation of cellular medicines in the areas of neurology, cardiology, and immunology. The convergence of cell biology and genetic engineering is creating fundamental new ways to impact disease. Founded in 2016 to capitalize on these technological breakthroughs, we are advancing our novel cell+gene platform to develop, manufacture, and deliver an entirely new generation of authentic and engineered cell therapies across three therapeutic areas: neurology, cardiology, and immunology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BlueRock TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Cambridge, Massachusetts
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://bluerocktx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/bluerocktx/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/BlueRockTx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bluerock Therapeutics Reveals Positive 36-Month Phase I Trial
    Bluerock Therapeutics Reveals Positive 36-Month Phase I Trial

    07 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251006770906/en/BlueRock-Therapeutics-reports-positive-36-month-results-from-Phase-I-trial-of-bemdaneprocel-for-treating-Parkinsons-disease

    BUSINESSWIRE
    07 Oct 2025
    Share Share
    Bayer-owned BlueRock lays off 50 employees, shuts Cambridge labs
    Bayer-owned BlueRock lays off 50 employees, shuts Cambridge labs

    26 Jun 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/bayer-owned-bluerock-lays-50-employees-shuts-cambridge-research-labs

    FIERCE BIOTECH
    26 Jun 2025
    Share Share
    Bayer and BlueRock's Journey in Cell Therapy Future
    Bayer and BlueRock's Journey in Cell Therapy Future

    02 Jun 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/sponsored/forging-future-cell-therapy-bayer-and-bluerocks-unique-journey

    FIERCE BIOTECH
    02 Jun 2025
    Share Share
    BlueRock Therapeutics' Cell Therapy Shows Positive 24-Month Data
    BlueRock Therapeutics' Cell Therapy Shows Positive 24-Month Data

    27 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240927256345/en

    BUSINESSWIRE
    27 Sep 2024
    Share Share
    BlueRock Gets FDA RMAT For Parkinson's Cell Therapy Bemdaneprocel
    BlueRock Gets FDA RMAT For Parkinson's Cell Therapy Bemdaneprocel

    31 May 2024

    // INDINPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/bluerock-therapeutics-receives-fda-rmat-designation-for-parkinsons-disease-cell-therapy-candidate-bemdaneprocel-15706

    INDINPHARMAPOST
    31 May 2024
    Share Share
    BlueRock phase I trial for Parkinson’s disease continues to show positive trends
    BlueRock phase I trial for Parkinson’s disease continues to show positive trends

    06 Mar 2024

    // PRESS RELEASE

    https://www.bayer.com/media/en-us/bluerock-therapeutics-phase-i-clinical-trial-for-parkinsons-disease-continues-to-show-positive-trends-at-18-months/

    PRESS RELEASE
    06 Mar 2024
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search